Inspection Record

Eugia Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2026-02-04 3 findingsDeviation, CAPA, and investigationStability and storageRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

2Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

3Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

About this record

Extracted automatically from the document of the Health Canada inspection on 2026-02-04. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Eugia Pharma Inc. company profile — full history Health Canada documents, 2026 Go to Findings search